gentiopicroside has been researched along with Alcoholic Fatty Liver in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, BW; Jiang, M; Jin, Q; Li, X; Lian, LH; Nan, JX; Song, SZ; Wu, YL; Xia, KL; Zhang, Y | 1 |
1 other study(ies) available for gentiopicroside and Alcoholic Fatty Liver
| Article | Year |
|---|---|
Liver kinase B1/AMP-activated protein kinase-mediated regulation by gentiopicroside ameliorates P2X7 receptor-dependent alcoholic hepatosteatosis.
Topics: Acetyl-CoA Carboxylase; Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Cells, Cultured; Down-Regulation; Ethanol; Fatty Liver, Alcoholic; Humans; Inflammasomes; Interleukin-1beta; Iridoid Glucosides; Lipid Peroxidation; Lipogenesis; Lipopolysaccharides; Macrophages; Male; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphorylation; PPAR alpha; Protein Serine-Threonine Kinases; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7; Sterol Regulatory Element Binding Protein 1; Transaminases; Triglycerides; Up-Regulation | 2018 |